GL1X · GenesisL1 explorer

MolNFT v1 · #168887 · protein

Structure of human SHP2 in complex with inhibitor iacs-13909

6WU8 · Tyrosine-protein phosphatase non-receptor type 11: “Structure of human SHP2 in complex with inhibitor iacs-13909”. X-ray diffraction, 1 ligand (U9Y), 9 pockets (best druggability 0.80). MolNFT v1 #168887 on GenesisL1: 3D structure…

PDB
6WU8
Type
protein
Length
991 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein phosphatase non-receptor type 11
EC
3.1.3.48
UniProt
Q06124
Ligands
U9Y
Pockets
9 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 29% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein49430% helix, 27% strandQ06124
BTyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein49728% helix, 26% strandQ06124

Ligands and binding sites

  • U9Y · 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-amine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18430.800.8379empty
28070.770.8181U9Y
34140.670.8043U9Y
41870.580.8132empty
51330.510.8026empty

Interfaces

1 interface between chains.

  • A–B · 952 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 6WU8 · Structure of human SHP2 in complex with inhibitor IACS-13909 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.